Vitamin D in the complex treatment of tuberculosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Tuberculosis treatment is long-term, continuous for at least 6 months, includes a complex of 4-6 anti-tuberculosis drugs. In the course of treatment, there may be unwanted and side effects from drugs. At all times of the existence of the disease, people have been looking for effective methods of treatment based on non-specific treatment. Pathogenetic treatment at the stage of primary treatment should maximize the effectiveness of treatment. The appointment of hepatoprotectors, immunomodulators, vitamins is mandatory. One of the drugs discussed in scientific publications is vitamin D and its role in the treatment of tuberculosis. There are different opinions, the difficulty of an objective assessment of the value of vitamin D in the treatment of tuberculosis is associated with the complexity of evaluating the effectiveness. But, it must be admitted that in recent years, very much attention has been paid to the importance of vitamin D. In this paper, we propose to consider the domestic drug “Osteo-Vit D3”, which is recommended to be combined with antibiotic therapy. The term “osteobiotic” was proposed by the developers. This terminology is due to the ability to neutralize the negative impact of various drugs on the musculoskeletal system.

Full Text

Restricted Access

About the authors

Dmitry G. Elistratov

Parapharm LLC

Email: dge117@mail.ru

General Director

Russian Federation, Penza

Ekaterina P. Eremenko

FSBEI HE “Samara State Medical University” of the Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: eremenko.ep@mail.ru
ORCID iD: 0000-0001-5909-4070

Candidate of Medicine, Associate Professor, Department of Phthisiology and Pulmonology

Russian Federation, Samara

References

  1. Borodulin B.E., Borodulina E.A., Eremenko E.P. Outpatient phthisiatrics. M.: KNORUS; 2022: 420.
  2. Borodulina E., Vdoushkina E., In’kova A. Pulmonary tuberculosis in patients with HIV infection. Vrach. 2020; 31(1): 37-43. (in Russian).
  3. Davydkin I., Osadchuk A., Borodulina E., et al. Infiltrative pulmonary tuberculosis, peptic ulcer disease and HIV infection (comorbidity and multimorbidity of diseases). Nauka i innovatsii v meditsine. 2016; 1(1): 19-24. (in Russian).
  4. Santalova G., Borodulina E., Kudlai D., et al. Rheumatic diseases and tuberculosis infection in children and adults. Tuberculosis and lung diseases. 2019; 97(2): 50-55 (in Russian).
  5. Eremenko E., Borodulina E., Amosova E. HIV infection in children as a risk factor for tuberculosis. Tuberculosis and lung diseases. 2017; 95(1): 18-21(in Russian).
  6. Jaimni V., Shasty B., Madhyastha S., et al. Association of Vitamin D Deficiency and Newly Diagnosed Pulmonary Tuberculosis. Pulm Med. 2021 Jan 15;2021:5285841. doi: 10.1155/2021/5285841
  7. Aranow C. Vitamin D and the immune system. J. Investig. Med. 2011; 59 (6): 881-6. doi: 10.2310/JIM.0b013e31821b8755. PMID: 21527855; PMCID: PMC3166406.
  8. Sutaria N., Liu C.-T., Chen T.C. Vitamin D status, receptor gene polymorphisms, and supplementation on tuberculosis: a systematic review of case-control studies and randomized controlled trials. J. Clin. Transl. Endocrinol. 2014, 1 (4): 151-60. DOI: 10.1016 / j.jcte.2014.08.001
  9. Brighenti S., Bergman P., Martineau A.R. Vitamin D and tuberculosis: where next? J. Intern. Med. 2018, 284 (2). DOI: 10.1111/ joim.12777. PMID: 29804293.
  10. Papagni R., Pellegrino C., et al. Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients. International Journal of Molecular Sciences. 2022; 23 (7): 3860. DOI: 10.3390/ ijms23073860
  11. Kombila U.D., Manomba Boulingui C., Ibinga L.D., et al. Difficultés et Obstacles dans la Prise en Charge de la Tuberculose Multirésistante au Centre Hospitalier et Universitaire de Libreville: Étude Rétrospective de 2017 à 2020. Health Sciences and Disease. 2021, 22 (11). Retrieved from https://www.hsd-fmsb.org/index.php/ hsd/article/view/3112
  12. Coussens A.K., Wilkinson R.J., Hanifa Y., et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Journal information: Proceedings of the National Academy of Sciences. 2021, 109 (38): 15449-15454. DOI: 10.1073/ pnas.1200072109
  13. Davies P.D., Martineau A.R. Vitamin D and tuberculosis: more effective in prevention than treatment? Int. J. Tuberc. Lung. Dis. 2015, 19 (8): 876-7. doi: 10.5588/ijtld.15.0506. PMID: 26162349.
  14. Jolliffe D.A., Ganmaa D., Wejse C., et al. Adjunctive vitamin D in tuberculosis treatment: meta-analysis of individual participant data. European Respiratory Journal, 2019, 53 (3): 1802003. doi: 10.1183/13993003.02003-2018
  15. Cai L., Wang G., Zhang P., et al. The Progress of the Prevention and Treatment of Vitamin D to Tuberculosis. Front. Nutr. 2022, 9: 873890. doi: 10.3389/fnut.2022.873890. PMID: 35662926; PMCID: PMC9159148.
  16. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355(9204):618-621.
  17. Samylina I.A., Strukov V.I., Petrova E.V., et al. Osteoprotective properties of a combination of HDBA complex with vitamins D3 and B6 («Osteo-Vit D3»). Pharmacology: experiment and clinic. 2020, 69 (1): 48-56.
  18. Elistratov D.G. Osteo-Vit D3 and Selenbio fo vomen in the prevention of COVID-19 and post-covid complications. Meditsinskaya sestra (The Nurse), 2022; 24 (2): 42-48 DOI: https://doi. org/10.29296/25879979-2022-02-01
  19. Vitamin D deficiency in adults: diagnosis, treatment and prevention: clinical guidelines / Russian Association of Endocrinologists [et al.]. M., 2015. P. 22.
  20. Moiseeva I.Ya., Sergeeva-Kondrachenko M.Yu., Strukov V.I. et al. Prospects for the use of xenobiotic drugs in antibacterial therapy. Terapevt. 2022; 10: 31-37.
  21. Pittas AG, Kawahara T, Jorde R, Dawson-Hughes B, Vickery EM, Angellotti E, Nelson J, Trikalinos TA, Balk EM. Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes : A Systematic Review and Meta-analysis of Individual Participant Data From 3 Randomized Clinical Trials. Ann Intern Med. 2023 Feb 7. doi: 10.7326/M22-3018. Epub ahead of print. PMID: 36745886.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies